Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 24, 2016
Pharmacy Choice - Pharmacy News - July 24, 2016

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
7/22/16 - Award-Winning CoolSculpting(R) Procedure Now FDA-Cleared to Reduce Fat
--Atlantic Plastic Surgery Center is excited to announce the expanded clearance from the U.S. Food and Drug Administration for the treatment of visible fat bulges of bra fat, back fat and underneath the buttocks. The CoolSculpting procedure is already FDA- cleared for treatment of the double chin, thigh, abdomen and love handles. Market research sh
7/22/16 - Citron Pharma Launches Rosuvastatin Calcium Tablets [Daily Star, The (Lebanon)]
Citron Pharma LLC, a rapidly growing, US based, generic pharmaceutical company confirmed that on Tuesday, July 19, its licensing partner received final approval from the U.S. Food and Drug Administration for their Abbreviated New Drug Application for Rosuvastatin Calcium 5, 10, 20 and 40 mg tablets, the generic version of AstraZeneca's CRESTOR tabl
7/22/16 - TO YOUR GOOD HEALTH WATCHMAN device is alternative treatment
ROACH: I have been diagnosed with a-fib. For various reasons, it has been determined that I should not be on blood thinners for any sustained length of time. I know that the device has been in use in Europe for about eight years but only recently has been approved by the Food and Drug Administration and Medicare.
7/21/16 - 3 pharma firms get USFDA nod for blockbuster cholesterol drug [Tripoli Post, The (Libya)]
In what could boost their fortunes significantly, three Indian companies Sun Pharma, Aurobindo Pharma and Glenmark Pharma have received approval from the United States Food and Drug Administration to manufacture and market generic versions of a blockbuster cholesterol drug, Crestor, in the American market. According to IMS Health, a global informat
7/21/16 - Citron Pharma Launches Rosuvastatin Calcium Tablets
Citron Pharma LLC, a rapidly growing, US based, generic pharmaceutical company confirmed that on Tuesday, July 19, its licensing partner received final approval from the U.S. Food and Drug Administration for their Abbreviated New Drug Application for Rosuvastatin Calcium 5, 10, 20 and 40 mg tablets, the generic version of AstraZeneca's CRESTOR ® t
7/21/16 - Lice Aunties Opens New Treatment Center in Burlington
Lice Aunties, a locally owned and operated professional head lice removal company, has opened its second location in Burlington, MA. Lice Aunties offers head lice screening and guaranteed, one-and-done lice treatments. The Lice Aunties are certified operators of the AirAllé, an FDA- cleared medical device that kills head lice and lice eggs using c

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415